반응식
[CH:1]1([O:32][P:33]([O-:36])([O-:35])=[O:34])[CH:6]([O:7][P:8]([O-:11])([O-:10])=[O:9])[CH:5]([O:12][P:13]([O-:16])([O-:15])=[O:14])[CH:4]([O:17]P([O-])([O-])=O)[CH:3]([O:22]P([O-])([O-])=O)[CH:2]1[O:27]P([O-])([O-])=O.[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[OH-].[Na+]>C(O)C>[C@H:4]1([OH:17])[CH:3]([OH:22])[C@@H:2]([OH:27])[C@@H:1]([O:32][P:33]([OH:36])([OH:35])=[O:34])[CH:6]([O:7][P:8]([OH:10])([OH:11])=[O:9])[C@@H:5]1[O:12][P:13]([OH:15])([OH:16])=[O:14]참가 물질
4
실험 절차
100 ml of the fraction containing D-myo-inositol-1.2.6-triphosphate obtained in Example 15 was neutralized to a pH of about 7 with an aqueous solution of NaOH. After addition of 100 ml ethanol the volume of the solution was reduced by evaporation and the sodiumsalt was precipitated, centrifuged, recrystallized and dried in vacuum. The purified sodiumsalt of D-myo-inositol-1.2.6-triphosphate obtained was structurally confirmed by analysis with H-NMR.
후처리
- customwas reduced by evaporation
- customthe sodiumsalt was precipitated
- customrecrystallized
- customdried in vacuum
출처 및 근거
- ORD 기록
- ord-bc91b0ea600744548cec0081e6df62c8
- 출처 데이터셋
- uspto-grants-1989_07
- 특허 번호
- US04851560
연결된 노트
불러오는 중…